How Geneticist Damir Musaev Became a PhD at Yale University and Landed at a Top Law Firm With $2 Billion in Revenue (limon.kg)
What do a fish embryo nicknamed the “zombie mutant,” an mRNA molecule research at Yale University, and one of the most powerful law firms in the world, Goodwin, have in common? They are all chapters in the story of Damir Musaev from Samarkand, who grew up carrying cancer samples to his grandfather’s lab, applied to an American university to become a doctor, and ended up earning a PhD from Yale University. “My current role is at Goodwin. We have more than 3,000 lawyers around the world, across the US, Europe, and Asia. I am part of the Life Sciences department. What we do is help pharmaceutical companies, biotech companies, and sometimes even universities when they make a discovery or develop a new drug to get a patent for that invention. In the US, it typically gives you 20 years of exclusive rights, meaning you're the only one who can make and sell that particular drug. After 20 years, it becomes public,” Musaev explained. “We give strategic advice: whether they need to develop the drug further, whether they should file for a patent now or wait, and so on.”
Read the limon.kg article for more.